Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ILOSONE

ERYTHROMYCIN ESTOLATE

Standard Dose
EQ 125MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ILOSONE is listed in Drugs@FDA under application 061895 (ANDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength TABLET, CHEWABLE;ORAL - EQ 125MG BASE Sponsor DISTA Submission history Latest submission status date: 1991-11-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ILOSONE is listed in Drugs@FDA under application 061895 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ESTOLATE Form and strength TABLET, CHEWABLE;ORAL - EQ 125MG BASE Sponsor DISTA Submission history Latest submission status date: 1991-11-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.